Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04946344
Other study ID # IRB00033618 - Cherokee
Secondary ID U01AR068658
Status Completed
Phase N/A
First received
Last updated
Start date May 12, 2022
Est. completion date April 20, 2023

Study information

Verified date June 2024
Source Wake Forest University Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to develop and demonstrate the effectiveness of a systematic, practical, cost-effective diet-induced weight loss and exercise intervention in Cherokee, North Caroling that will recruit American Indian participants; that can reduce pain and improve other clinical outcomes in knee OA patients. This pragmatic community-based trial will determine if the investigators previous findings translate to real-world settings and will address common concerns about barriers to effectiveness/ implementation.


Description:

Obesity is a modifiable risk factor for knee osteoarthritis (OA), and weight loss is an effective non-pharmacologic treatment to reduce pain. Recently, the investigators determined that under ideal, highly controlled circumstances, a diet-induced weight loss of 10% combined with exercise was significantly better at reducing pain than either intervention alone. Compared to the investigators previous longterm weight loss and exercise trials of knee OA, the diet-induced weight loss and exercise group was twice as effective at relieving pain. Whether the investigators results can be generalized to less rigorously monitored patient cohorts is unknown. Thus the challenge the investigators now face is to provide the practical means to implement this proven treatment in the community setting. This study aims to develop and demonstrate the effectiveness of a systematic, practical, cost-effective diet-induced weight loss and exercise intervention in both urban and rural communities that can reduce pain and improve other clinical outcomes in knee OA patients. Participants will be 30 ambulatory, community-dwelling, overweight and obese men and women who meet the American College of Rheumatology clinical criteria for knee OA. The primary aim is to determine whether a pragmatic, community-based 3-month diet-induced weight loss and exercise intervention implemented in Cherokee, North Carolina significantly decreases knee pain in overweight and obese adults with knee OA relative to an attention control group. Secondary aims will determine whether this intervention improves self-reported function, health-related quality of life, and mobility. The investigators will also establish the cost-effectiveness of this pragmatic, community-based, multimodal diet-induced weight-loss and exercise program by conducting cost-effectiveness and budgetary impact analyses using data from the current trial in a validated computer-simulated model of knee OA.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date April 20, 2023
Est. primary completion date April 20, 2023
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria: - age = 50 - Knee Pain plus American College of Radiology (ACR) Criteria for Knee Osteoarthritis - BMI = 25 = kg/m2 Exclusion Criteria: - Significant co-morbid disease that would threaten safety or impair ability to participate in interventions or testing (Blindness; Type 1 diabetes; Severe coronary artery disease) - Not sufficiently overweight or obese, BMI < 27 kg/m2 - Not having knee pain - Inability to finish 3-month study or unlikely to be compliant (Planning to leave area > 1 month during the next 3 months; Unwilling to change eating or physical activity habits; Unwilling to discontinue pain medication use for 3 days prior to testing visit) - Living > 30 minutes from the intervention site - Age, age < 50 - Other conditions that may prohibit the effective delivery of the intervention (Unable to provide own transportation to exercise center; Unable to read or write)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Diet & Exercise
Participants will attend exercise and diet classes.
Attention Control
Participants will attend healthy living classes and receive phone calls/emails/texts.

Locations

Country Name City State
United States Ginger Welch Complex Cherokee North Carolina
United States Wake Forest University/Wake Forest University Health Sciences Winston-Salem North Carolina

Sponsors (3)

Lead Sponsor Collaborator
Wake Forest University National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), University of North Carolina, Chapel Hill

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Physical Performance Battery (SPPB) - Balance A score lower than 10 indicates one or more mobility limitations. A score lower than 10 is predictive of all-cause mortality Baseline and Month 3
Other Physical Performance Battery (SPPB) - Walking Speed A score lower than 10 indicates one or more mobility limitations. A score lower than 10 is predictive of all-cause mortality Baseline and Month 3
Other Physical Performance Battery (SPPB) - Chair Rise A score lower than 10 indicates one or more mobility limitations. A score lower than 10 is predictive of all-cause mortality Baseline and Month 3
Other Physical Performance Battery (SPPB) - Stair Activity Ascending and descending stair activity measured by the time (in seconds) it takes to ascend and descend a flight of 8 steps with 20cm (8 inch) step height Baseline and Month 3
Other EuroQol Quality of Life Evaluates the generic quality of life developed in Europe and widely used. The EuroQol Quality (EQ)-five dimensions (5D) descriptive system is a preference-based Health-related quality of life (HRQL) measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression Baseline and Month 3
Other The Walking Efficacy for Duration Scale Duration is a measure to determine participants' beliefs in their physical capability to successfully complete incremental 5-minute intervals (5 to 40 minutes) at a moderately fast pace For each item, participants indicate their confidence to execute the behavior on a 100-point percentage scale comprised of 10-point increments, ranging from 0% (not at all confident) to 100% (highly confident). Total strength for each measure of self-efficacy is then calculated by summing the confidence ratings and dividing by the total number of items in the scale, resulting in a maximum possible efficacy score of 100 Baseline and Month 3
Other The Positive and Negative Affect (PANAS) Measures both positive and negative affect, leading to more insightful outlooks regarding participants' feeling states. This scale consists of 20 items that reflect the intensity of how the participant "feels" right now Baseline and Month 3
Other The Gait Efficacy/Environmental Efficacy Scale Will ask the participants' confidence in performing certain activities Baseline and Month 3
Other Satisfaction With Life Scale Focused to assess global life satisfaction - Participants indicate how much they agree or disagree with each of the 5 items using a 7-point scale that ranges from 7 strongly agree to 1 strongly disagree Baseline and Month 3
Other The Weight Efficacy Lifestyle Questionnaire (WEL) A 20-item measure employed to assess self-efficacy for weight management - 10-point Likert scale ranging from 0 (not confident) to 9 (very confident) to resist the desire to eat. Baseline and Month 3
Other The Perceived Stress Scale (PSS) Will measure the degree to which people perceive their lives as stressful - PSS-10 scores are obtained by reversing the scores on the four positive items: For example, 0=4, 1=3, 2=2, etc. and then summing across all 10 items. Items 4, 5, 7, and 8 are the positively stated items. Scores around 13 are considered average. Higher scores indicate higher stress. Baseline and Month 3
Other The Adherence Self-efficacy Questionnaire Assess beliefs in one's ability (confidence) to continue exercising at various intensities and frequencies - This 12-item scale assessed patient confidence to carry out important treatment-related behaviors related to adhering to treatment plans, including medication regimen adherence and following plans for nutrition, exercise, etc, in the face of barriers - Higher scores indicate a greater level of self-efficacy Baseline and Month 3
Other Pain Catastrophizing Scale (PCS) People are asked to indicate the degree to which they have the above thoughts and feelings when they are experiencing pain using the 0 (not at all) to 4 (all the time) scale. A total score is yielded (ranging from 0-52), along with three subscale scores assessing rumination, magnification and helplessness Baseline and Month 3
Other Knee Injury and Osteoarthritis Outcome Score (KOOS) The KOOS questionnaire will be used to assess the patient's opinion about their knee and associated problems. The KOOS evaluates both short-term and long-term consequences of knee injury and also consequences of primary osteoarthritis (OA) - the mean score of the individual items of each subscale and divide by 4 (the highest possible score for a single answer option). Traditionally in orthopedics, 100 indicates no problems and 0 indicates extreme problems Baseline and Month 3
Other Intermittent and Constant Osteoarthritis Pain (ICOAP) The ICOAP assesses pain in individuals with knee osteoarthritis taking into account both constant and intermittent pain experiences - the 11 items are scored from 0-4 with 0 being no pain and 4 being extreme pain - maximum score = 100 Baseline and Month 3
Other (DHQ) Dietary History Questionnaire The diet history method is a detailed retrospective dietary assessment which obtains details of individual foods, and comprehensive information about foods eaten less regularly Baseline and Month 3
Other Behavioral Risk Factor Surveillance System (BRFSS) The BRFSS is a cross-sectional telephone survey that measures health literacy - the nation's premier system of health-related telephone surveys that collect state data about U.S. residents regarding their health-related risk behaviors, chronic health conditions, and use of preventive services. Baseline and Month 3
Other The Physical Activity Scale for the Elderly (PASE) The PASE assesses the types of activities typically chosen by older adults (walking, recreational activities, exercise, housework, yard work, and caring for others. It uses frequency, duration, and intensity level of activity over the previous week to assign a score, ranging from 0 to 793, with higher scores indicating greater physical activity -Total PASE scores are computed by multiplying activity weights by activity frequencies Baseline and Month 3
Other The Montreal Cognitive Assessment (MOCA) During the MOCA, a health professional asks a patient a series of questions designed to test a range of everyday mental skills. The maximum MOCA score is 30 points. A score of 20 to 24 suggests mild dementia, 13 to 20 suggests moderate dementia, and less than 12 indicates severe dementia Baseline and Month 3
Other Center for Epidemiologic Studies Depression Scale The score is the sum of the 20 questions. Possible range is 0-60. If more than four questions are missing answers, do not score the Center for Epidemiologic Studies Depression (CES-D) questionnaire. A score of 16 points or more is considered depressed Baseline and Month 3
Other Cost-effectiveness Resource utilization will be collected by questionnaire, with domains including visits to clinicians (physicians, nurses, physical therapists, others), tests, medications, injections, surgery, alternative therapies. The Work Productivity and Activity Impairment index (WPAI) will be used to assess absenteeism and reduced productivity while at work Month 3
Primary Western Ontario McMasters Universities Osteoarthritis Index (WOMAC) - Knee Pain Western Ontario McMasters Universities Osteoarthritis Index (WOMAC) pain subscale in overweight and obese adults with knee OA compared to an attention-control group - The pain index assesses participants' pain on the same scale, ranging from 0 (none) to 4 (extreme). The pain subscale consists of 5 items. Normalized values are reported. To calculate, the mean score of the individual items of is divided by 4 (the highest possible score for a single answer option). The mean of the observed items is then multiplied by 100 and subtracted from 100. Total scores can range from 0-100, with larger scores indicating greater pain. Month 3
Secondary Western Ontario McMasters Universities Osteoarthritis Index (WOMAC) - Function Western Ontario McMasters Universities Osteoarthritis Index (WOMAC) function subscale in overweight and obese adults with knee OA compared to an attention-control group - participants indicate on a scale from 0 (none) to 4 (extreme) the degree of difficulty experienced in the last week due to knee OA. Scores range from 0 to 96 for the total WOMAC where 0 represents the best health status and 96 the worst possible status. The higher the score, the poorer the function. Month 3
Secondary Health Related Quality of Life (SF-36) The physical dimension of the SF-36 is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. A higher score represents a more favorable health state. Month 3
Secondary Distance Walked - Mobility (Six Minute Walk) To determine whether a pragmatic, community-based, 3-month, diet-induced weight-loss and exercise intervention improves 6-minute walk distance (an accepted measure of mobility) in overweight and obese adults with knee OA compared to an attention control group. Month 3
See also
  Status Clinical Trial Phase
Completed NCT04657926 - A Trial of APPA in the Treatment of Knee Osteoarthritis Phase 2
Completed NCT02536833 - A Study Evaluating the Safety, Tolerability, and Efficacy of SM04690 Injected in the Target Knee Joint of Moderately to Severely Symptomatic Osteoarthritis Subjects Phase 2
Completed NCT03014037 - Comparing Mesenchymal Stem Cell Counts in Unilateral vs. Bilateral Posterior Superior Iliac Spine Bone Marrow Aspiration N/A
Recruiting NCT05937542 - A Qualitative Investigation of CLEAT Participants
Completed NCT03644615 - A Mindfulness Program (MBSR) in the Management of Symptomatic Hip and Knee Osteoarthritis N/A
Recruiting NCT06061367 - Muscles Strength and Gait Parameteres After TKA
Withdrawn NCT04976972 - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT03850665 - Comparison of Functional Outcome in Patients After Hip Arthroplasty Depending on Surgical Approach N/A
Completed NCT02826902 - Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial N/A
Completed NCT04402502 - Dynamic 4DCT to Examine Wrist Carpal Mechanics N/A
Completed NCT02923700 - Leukocyte-rich PRP vs Leukocyte-poor PRP for the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial Phase 4
Completed NCT04564053 - Study of Safety, Tolerability and Pharmacokinetics of LNA043 in Japanese Osteoarthritis Participants Phase 1
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Not yet recruiting NCT05036174 - Diphenhydramine Ointment for Knee Osteoarthritis N/A
Recruiting NCT02666443 - Low Dose Dexamethasone in Supraclavicular Blocks N/A
Recruiting NCT02912429 - Onlay vs. Inlay Patellofemoral Arthroplasty N/A
Active, not recruiting NCT02723929 - Effects of tDCS and tUS on Pain Perception in OA of the Knee
Withdrawn NCT02921594 - Kinematic Comparison of Vanguard XP and Vanguard CR Total Knee Arthroplasties N/A
Terminated NCT02820766 - Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting N/A